thiamine has been researched along with Endotoxin Shock in 86 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The mean malondialdehyde level was higher in patients of sepsis (1." | 9.51 | Effect of Supplementation of Vitamin C and Thiamine on the Outcome in Sepsis: South East Asian Region. ( Ap, GR; Daga, MK; Koner, BC; Kumar, N; Mawari, G; Mishra, R; Rohatgi, I; Singh, VK, 2022) |
| "This study explored the efficacy of hydrocortisone combined with vitamin C and thiamine (HVT) in the treatment of sepsis/septic shock." | 9.41 | Hydrocortisone Combined with Vitamin C and Thiamine in the Treatment of Sepsis/Septic Shock: A Systematic Review with Meta-Analysis and Trial Sequential Analysis. ( Lu, D; Mao, W, 2023) |
| "There is a conflicting body of evidence regarding the benefit of vitamin C, thiamine, and hydrocortisone in combination as an adjunctive therapy for sepsis with or without septic shock." | 9.22 | Vitamin C, Thiamine, and Hydrocortisone in the Treatment of Sepsis: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. ( Alzghoul, BN; Banifadel, M; Borok, Z; Hyde, R; Jantz, M; Khasawneh, M; Reddy, R; Sutchu, S; Urbine, D; Venigandla, H; Zayed, Y, 2022) |
| "Among patients with sepsis and septic shock, a combination therapy of hydrocortisone, ascorbic acid, and thiamine, compared with placebo, could reduce the duration of vasopressor use and SOFA scores during the first 72 h." | 9.12 | Effect of Combined Hydrocortisone, Ascorbic Acid and Thiamine for Patients with Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. ( Hu, B; Hu, C; Huang, W; Li, J; Wu, T; Xu, Q, 2021) |
| "We aim to determine if thiamine combined vitamin C can reduce mortality in patients with sepsis or septic shock." | 9.12 | Thiamine combined with vitamin C in sepsis or septic shock: a systematic review and meta-analysis. ( Gao, Y; Ge, Z; Huang, J; Li, Y; Liu, Y; Lu, X; Walline, JH; Xiang, J; Yu, S; Zhao, L, 2021) |
| "To assess the effect from individual component in combinations of steroid, ascorbic acid, and thiamine on outcomes in adults with sepsis and septic shock with component network meta-analysis (NMA)." | 9.12 | Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis. ( Au, SY; Fong, KM; Ng, GWY, 2021) |
| "Initial studies in patients with sepsis and septic shock demonstrated beneficial effects of ascorbic acid, thiamine, and steroids as monotherapy or in combination without safety concerns." | 9.05 | Vitamin C, Thiamine, and Steroids in the Sepsis Conquest: Replete to Defeat. ( Grace, Y; Guirguis, E; Maarsingh, H; Tkachuk, E; Tran, TC, 2020) |
| "To describe thiamine supplementation incidence in patients with AUD and various critical illnesses (alcohol withdrawal, septic shock, traumatic brain injury [TBI], and diabetic ketoacidosis [DKA]) in the United States." | 8.12 | Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness : A Nationwide Retrospective Observational Study. ( Balaji, L; Berg, KM; Donnino, MW; Grossestreuer, AV; Holmberg, MJ; Issa, MS; Kronen, R; Moskowitz, A; Patel, PV; Pawar, RD; Thompson, G, 2022) |
| " Though further investigation is warranted, utilization of IV vitamin C, thiamine, and hydrocortisone in patients with sepsis or septic shock may be a treatment option worth considering." | 7.96 | Vitamin C and Thiamine for Sepsis and Septic Shock. ( Gillion, AR; Mitchell, AB; Muthiah, MP; Ryan, TE; Wells, LD, 2020) |
| "Treatment of pediatric septic shock with thiamine was followed by rapid improvement in physiologic and clinical outcomes after prolonged hyperlactatemia." | 7.91 | Matched Retrospective Cohort Study of Thiamine to Treat Persistent Hyperlactatemia in Pediatric Septic Shock. ( Berg, RA; Blowey, B; Fitzgerald, JC; Ganetzky, R; Keele, L; Murali, CN; Sutton, RM; Weiss, SL, 2019) |
| "Our results suggest that the early use of intravenous vitamin C, together with corticosteroids and thiamine, are effective in preventing progressive organ dysfunction, including acute kidney injury, and in reducing the mortality of patients with severe sepsis and septic shock." | 7.85 | Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. ( Catravas, J; Hooper, MH; Khangoora, V; Marik, PE; Rivera, R, 2017) |
| "Sepsis is a life-threatening condition characterized by multiorgan dysfunction due to an exaggerated host response to infection associated with a homeostatic failure." | 7.01 | Thiamine pharmaconutrition in sepsis: Monotherapy, combined therapy, or neither? Current evidence on safety and efficacy. ( Hardy, G; Manzanares, W; Novoa, J, 2023) |
| "Sepsis and septic shock are severe medical conditions that can damage multiple organs with a higher risk of mortality." | 6.82 | Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review. ( Lee, YR; Varughese, JT; Vo, K, 2022) |
| " However, many questions remain regarding the optimal dosing regimens and plasma concentrations, timing of administration, and adverse effects of vitamin C and thiamine." | 6.66 | Treating sepsis with vitamin C, thiamine, and hydrocortisone: Exploring the quest for the magic elixir. ( Halpern, NA; Obi, J; Pastores, SM; Ramanathan, LV; Yang, J, 2020) |
| "Sepsis is defined as the dysregulated host response to an infection resulting in life-threatening organ dysfunction." | 6.58 | A review of micronutrients in sepsis: the role of thiamine, l-carnitine, vitamin C, selenium and vitamin D. ( Belsky, JB; Jacob, V; Lee, PJ; Sather, JE; Wira, CR, 2018) |
| " The mean malondialdehyde level was higher in patients of sepsis (1." | 5.51 | Effect of Supplementation of Vitamin C and Thiamine on the Outcome in Sepsis: South East Asian Region. ( Ap, GR; Daga, MK; Koner, BC; Kumar, N; Mawari, G; Mishra, R; Rohatgi, I; Singh, VK, 2022) |
| "This study explored the efficacy of hydrocortisone combined with vitamin C and thiamine (HVT) in the treatment of sepsis/septic shock." | 5.41 | Hydrocortisone Combined with Vitamin C and Thiamine in the Treatment of Sepsis/Septic Shock: A Systematic Review with Meta-Analysis and Trial Sequential Analysis. ( Lu, D; Mao, W, 2023) |
| "There is a conflicting body of evidence regarding the benefit of vitamin C, thiamine, and hydrocortisone in combination as an adjunctive therapy for sepsis with or without septic shock." | 5.22 | Vitamin C, Thiamine, and Hydrocortisone in the Treatment of Sepsis: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. ( Alzghoul, BN; Banifadel, M; Borok, Z; Hyde, R; Jantz, M; Khasawneh, M; Reddy, R; Sutchu, S; Urbine, D; Venigandla, H; Zayed, Y, 2022) |
| "To assess the effect from individual component in combinations of steroid, ascorbic acid, and thiamine on outcomes in adults with sepsis and septic shock with component network meta-analysis (NMA)." | 5.12 | Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis. ( Au, SY; Fong, KM; Ng, GWY, 2021) |
| "Among patients with sepsis and septic shock, a combination therapy of hydrocortisone, ascorbic acid, and thiamine, compared with placebo, could reduce the duration of vasopressor use and SOFA scores during the first 72 h." | 5.12 | Effect of Combined Hydrocortisone, Ascorbic Acid and Thiamine for Patients with Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. ( Hu, B; Hu, C; Huang, W; Li, J; Wu, T; Xu, Q, 2021) |
| "We aim to determine if thiamine combined vitamin C can reduce mortality in patients with sepsis or septic shock." | 5.12 | Thiamine combined with vitamin C in sepsis or septic shock: a systematic review and meta-analysis. ( Gao, Y; Ge, Z; Huang, J; Li, Y; Liu, Y; Lu, X; Walline, JH; Xiang, J; Yu, S; Zhao, L, 2021) |
| "Initial studies in patients with sepsis and septic shock demonstrated beneficial effects of ascorbic acid, thiamine, and steroids as monotherapy or in combination without safety concerns." | 5.05 | Vitamin C, Thiamine, and Steroids in the Sepsis Conquest: Replete to Defeat. ( Grace, Y; Guirguis, E; Maarsingh, H; Tkachuk, E; Tran, TC, 2020) |
| "The multisystem complications seen in severe thiamine deficiency can delay timely administration of high-dose thiamine, particularly in pregnancy, in which the classic triad of Wernicke-Korsakoff syndrome may not raise clinical suspicion due to rapid progression of neurological sequelae in this population." | 4.31 | Fetal demise and Wernicke-Korsakoff syndrome in a patient with hyperemesis gravidarum: a case report. ( Becker, M; DeSimone, A; Lopez-Pastrana, J; Olmsted, A, 2023) |
| "To describe thiamine supplementation incidence in patients with AUD and various critical illnesses (alcohol withdrawal, septic shock, traumatic brain injury [TBI], and diabetic ketoacidosis [DKA]) in the United States." | 4.12 | Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness : A Nationwide Retrospective Observational Study. ( Balaji, L; Berg, KM; Donnino, MW; Grossestreuer, AV; Holmberg, MJ; Issa, MS; Kronen, R; Moskowitz, A; Patel, PV; Pawar, RD; Thompson, G, 2022) |
| "Previous randomized trials of vitamin C, hydrocortisone, and thiamine on sepsis were limited by short-term vitamin C administration, heterogeneous populations, and the failure to evaluate each component's effect." | 4.12 | Vitamin C for ≥ 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study. ( Baek, MS; Jung, SY; Kim, WY; Lee, MT, 2022) |
| " Though further investigation is warranted, utilization of IV vitamin C, thiamine, and hydrocortisone in patients with sepsis or septic shock may be a treatment option worth considering." | 3.96 | Vitamin C and Thiamine for Sepsis and Septic Shock. ( Gillion, AR; Mitchell, AB; Muthiah, MP; Ryan, TE; Wells, LD, 2020) |
| "Triple therapy with steroids, vitamin C and thiamine has been recently proposed as a safe and beneficial in patients with sepsis." | 3.96 | Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study. ( Biagioni, E; Brugioni, L; Coloretti, I; Gelmini, R; Girardis, M; Munari, E; Roat, E; Tosi, M; Venturelli, C; Venturelli, S, 2020) |
| "Treatment of pediatric septic shock with thiamine was followed by rapid improvement in physiologic and clinical outcomes after prolonged hyperlactatemia." | 3.91 | Matched Retrospective Cohort Study of Thiamine to Treat Persistent Hyperlactatemia in Pediatric Septic Shock. ( Berg, RA; Blowey, B; Fitzgerald, JC; Ganetzky, R; Keele, L; Murali, CN; Sutton, RM; Weiss, SL, 2019) |
| "Our results suggest that the early use of intravenous vitamin C, together with corticosteroids and thiamine, are effective in preventing progressive organ dysfunction, including acute kidney injury, and in reducing the mortality of patients with severe sepsis and septic shock." | 3.85 | Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. ( Catravas, J; Hooper, MH; Khangoora, V; Marik, PE; Rivera, R, 2017) |
| "Early detection of subclinical thiamine deficiency is a difficult task, as symptoms may be nonspecific." | 3.80 | Wernicke's encephalopathy in a malnourished surgical patient: a difficult diagnosis. ( Bonvecchio, C; Busani, S; Cautero, N; Gaspari, A; Girardis, M; Malagoli, M; Todeschini, A, 2014) |
| "Adult patients diagnosed with septic shock requiring norepinephrine at a rate of ≥0." | 3.30 | EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL). ( Abdelaty, M; Abdelrahim, M; Afzal, M; Akkari, AR; Bakdach, D; Bintaher, A; El-Enany, R; El-Hamid, M; Elbuzidi, A; Hashim, A; Hassan, I; Hssain, AA; Ibrahim, AS; Karic, E; Lance, M; Mitwally, H; Mohamed, A; Saad, MO; Shehatta, A; Shible, A, 2023) |
| "This pilot study enrolled septic shock patients admitted to the ICU of a tertiary teaching hospital from February 2019 to January 2020." | 3.30 | Effects of hydrocortisone combined with vitamin C and vitamin B1 versus hydrocortisone alone on microcirculation in septic shock patients: A pilot study. ( Huang, L; Huang, Y; Li, Q; Meng, S; Song, Q; Wang, H; Wang, J; Xie, J; Xu, J; Yang, S, 2023) |
| "Among adult patients with septic shock, early use of hydrocortisone, vitamin C, and thiamine combination therapy compared with placebo did not confer survival benefits." | 3.11 | Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial. ( Chen, QH; Gu, XH; Lyu, QQ; Shao, J; Yu, JQ; Zheng, RQ, 2022) |
| "Sepsis is a life-threatening condition characterized by multiorgan dysfunction due to an exaggerated host response to infection associated with a homeostatic failure." | 3.01 | Thiamine pharmaconutrition in sepsis: Monotherapy, combined therapy, or neither? Current evidence on safety and efficacy. ( Hardy, G; Manzanares, W; Novoa, J, 2023) |
| "In patients with septic shock, treatment with intravenous vitamin C, hydrocortisone, and thiamine, compared with intravenous hydrocortisone alone, did not significantly improve the duration of time alive and free of vasopressor administration over 7 days." | 2.94 | Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. ( Al-Bassam, W; Bailey, M; Bates, S; Bellomo, R; Bitker, L; Cioccari, L; Deane, AM; Dwivedi, DB; Eastwood, GM; Edney, SJ; Frei, DR; French, CJ; Fujii, T; Hajjar, LA; Hudson, EP; Hunt, AL; Judd, HL; Luethi, N; McCracken, P; McGain, F; Naorungroj, T; Oliveira, G; Orford, N; Orosz, J; Peppin, C; Shehabi, Y; Udy, AA; Yanase, F; Young, PJ, 2020) |
| "We included adult patients with septic shock who required a vasopressor within 1-24 h after admission between March 2018 and January 2019 at a tertiary hospital in Thailand." | 2.94 | Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial. ( Kunawut, P; Morakul, S; Petsakul, S; Sanguanwit, P; Singhatas, P; Tangsujaritvijit, V, 2020) |
| "In patients with septic shock, the combination of ascorbic acid, corticosteroids, and thiamine, compared with placebo, did not result in a statistically significant reduction in SOFA score during the first 72 hours after enrollment." | 2.94 | Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial. ( Andersen, LW; Becker, LB; Berg, KM; Chase, M; Cocchi, MN; Donnino, MW; Doshi, PB; Gong, J; Grossestreuer, AV; Hershey, M; Hilewitz, A; Hou, PC; Huang, DT; Korotun, M; McCannon, JB; Moskowitz, A; Ngo, L; Otero, RM; Sen, A; Sherwin, RL; Uduman, J, 2020) |
| "Septic shock is associated with poor outcomes." | 2.90 | Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan. ( Bailey, M; Bellomo, R; Deane, AM; Eastwood, GM; Frei, D; French, C; Fujii, T; Luethi, N; Orford, N; Shehabi, Y; Udy, AA; Young, PJ, 2019) |
| "Septic shock is a life-threatening condition with underlying circulatory and cellular/metabolic abnormalities." | 2.90 | Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial. ( Choi, SH; Chung, SP; Hwang, SY; Jo, IJ; Jo, YH; Kim, D; Kim, S; Kim, T; Kim, WY; Kim, YJ; Kong, T; Lee, HJ; Park, JE; Ryoo, SM; Shin, J; Shin, TG; Suh, GJ; You, KM, 2019) |
| "Septic shock is a common and highly morbid condition." | 2.90 | Ascorbic Acid, Corticosteroids and Thiamine in Sepsis (ACTS) protocol and statistical analysis plan: a prospective, multicentre, double-blind, randomised, placebo-controlled clinical trial. ( Andersen, LW; Donnino, MW; Grossestreuer, AV; Huang, DT; Moskowitz, A; Yankama, T, 2019) |
| "Sepsis and septic shock are severe medical conditions that can damage multiple organs with a higher risk of mortality." | 2.82 | Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review. ( Lee, YR; Varughese, JT; Vo, K, 2022) |
| "Adult patients with septic shock and elevated (> 3 mmol/L) lactate between 2010 and 2014." | 2.82 | Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study. ( Andersen, LW; Berg, KM; Chase, M; Cocchi, MN; Donnino, MW; Giberson, T; Moskowitz, A; Ngo, L; Smithline, H; Tidswell, M; Wolfe, R, 2016) |
| "Sepsis is a condition characterized by life-threatening organ dysfunction caused by a dysregulated host response to infection." | 2.82 | Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients. ( Bonderski, V; Krishnan, K; Rech, MA; Tednes, P; Wassermann, TB, 2022) |
| "The efficacy of intravenous thiamine to treat septic shock remains controversial." | 2.66 | Intravenous thiamine for septic shock: A meta-analysis of randomized controlled trials. ( Li, F; Qian, X; Wu, L; Zhang, Z, 2020) |
| " However, many questions remain regarding the optimal dosing regimens and plasma concentrations, timing of administration, and adverse effects of vitamin C and thiamine." | 2.66 | Treating sepsis with vitamin C, thiamine, and hydrocortisone: Exploring the quest for the magic elixir. ( Halpern, NA; Obi, J; Pastores, SM; Ramanathan, LV; Yang, J, 2020) |
| "Sepsis is defined as the dysregulated host response to an infection resulting in life-threatening organ dysfunction." | 2.58 | A review of micronutrients in sepsis: the role of thiamine, l-carnitine, vitamin C, selenium and vitamin D. ( Belsky, JB; Jacob, V; Lee, PJ; Sather, JE; Wira, CR, 2018) |
| "Survivors and non-survivors of septic shock were similar." | 1.62 | Thiamine Status in Children with Septic Shock from a Developing Country: A Prospective Case-Control Study. ( Attri, SV; Baranwal, AK; Jayashree, M; Kumar-M, P; Patial, A; Raj, KM; Saini, AG, 2021) |
| "Patients with septic shock requiring norepinephrine within 2 days of admission were retrospectively reviewed." | 1.56 | Association Between IV Thiamine and Mortality in Patients With Septic Shock: A Nationwide Observational Study. ( Aso, S; Doi, K; Fushimi, K; Hamasaki, Y; Iwagami, M; Matsui, H; Miyamoto, Y; Nangaku, M; Yasunaga, H, 2020) |
| "Among patients with sepsis or septic shock, the combination of hydrocortisone, vitamin C, and thiamine did not reduce mortality compared with placebo." | 1.56 | Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock: A Randomized Controlled Trial. ( Cen, Z; Chang, P; Guan, J; Guo, Y; Hu, J; Liao, Y; Liu, Z; Tang, Y; Wang, H; Zhao, M; Zhou, J, 2020) |
| "Thiamine was not associated with oxidative stress." | 1.40 | Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock. ( Azevedo, PS; Costa, NA; Cozzolino, SM; de Paiva, SA; de Souza Dorna, M; Fernandes, AA; Gut, AL; Minicucci, MF; Pimentel, JA; Zornoff, LA, 2014) |
| "She developed severe cardiac failure, which did not respond to classical treatment." | 1.32 | Ketosis and cardiac failure: common signs of a single condition. ( De Wijngaard, S; Diltoer, MW; Hubloue, I; Huyghens, LP; Lauwers, R; Troubleyn, J; Vercammen, MJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (5.81) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (1.16) | 29.6817 |
| 2010's | 29 (33.72) | 24.3611 |
| 2020's | 51 (59.30) | 2.80 |
| Authors | Studies |
|---|---|
| Park, JE | 3 |
| Jo, YH | 3 |
| Hwang, SY | 3 |
| Kim, WY | 4 |
| Ryoo, SM | 3 |
| Jang, DH | 2 |
| Kim, T | 3 |
| Kim, YJ | 3 |
| Kim, S | 3 |
| Cho, H | 2 |
| Lee, GT | 1 |
| Chung, SP | 3 |
| Choi, SH | 3 |
| Shin, TG | 3 |
| Suh, GJ | 3 |
| Wu, T | 1 |
| Hu, C | 1 |
| Huang, W | 1 |
| Xu, Q | 1 |
| Hu, B | 1 |
| Li, J | 5 |
| Fujii, T | 7 |
| Salanti, G | 1 |
| Belletti, A | 1 |
| Bellomo, R | 4 |
| Carr, A | 1 |
| Furukawa, TA | 1 |
| Luethi, N | 3 |
| Luo, Y | 1 |
| Putzu, A | 1 |
| Sartini, C | 1 |
| Tsujimoto, Y | 1 |
| Udy, AA | 5 |
| Yanase, F | 2 |
| Young, PJ | 3 |
| Krishnan, K | 1 |
| Wassermann, TB | 1 |
| Tednes, P | 1 |
| Bonderski, V | 1 |
| Rech, MA | 1 |
| Pawar, RD | 1 |
| Balaji, L | 2 |
| Grossestreuer, AV | 6 |
| Thompson, G | 1 |
| Holmberg, MJ | 2 |
| Issa, MS | 1 |
| Patel, PV | 3 |
| Kronen, R | 1 |
| Berg, KM | 4 |
| Moskowitz, A | 7 |
| Donnino, MW | 7 |
| Jung, SY | 1 |
| Lee, MT | 1 |
| Baek, MS | 1 |
| Ap, GR | 1 |
| Daga, MK | 1 |
| Mawari, G | 1 |
| Koner, BC | 1 |
| Singh, VK | 1 |
| Kumar, N | 2 |
| Rohatgi, I | 1 |
| Mishra, R | 1 |
| Wang, K | 1 |
| Yin, L | 1 |
| Song, Y | 1 |
| Zhang, M | 1 |
| Lu, Y | 1 |
| Wang, S | 1 |
| Ragoonanan, D | 1 |
| Tran, N | 1 |
| Modi, V | 1 |
| Morgan Nickelsen, P | 1 |
| Albertson, TE | 1 |
| Chenoweth, JA | 1 |
| Lewis, JC | 1 |
| Pugashetti, JV | 1 |
| Sandrock, CE | 1 |
| Morrissey, BM | 1 |
| Lyu, QQ | 1 |
| Zheng, RQ | 1 |
| Chen, QH | 1 |
| Yu, JQ | 1 |
| Shao, J | 1 |
| Gu, XH | 1 |
| Suárez-de-la-Rica, A | 3 |
| Croes, B | 3 |
| Ciudad, L | 3 |
| Vallejo, I | 3 |
| Mújica, J | 3 |
| Díaz-Almirón, M | 3 |
| Maseda, E | 3 |
| Blakeslee, PA | 1 |
| Hyrkäs, K | 1 |
| Olmsted, A | 1 |
| DeSimone, A | 1 |
| Lopez-Pastrana, J | 1 |
| Becker, M | 1 |
| Mohamed, A | 1 |
| Abdelaty, M | 1 |
| Saad, MO | 1 |
| Shible, A | 1 |
| Mitwally, H | 1 |
| Akkari, AR | 1 |
| Elbuzidi, A | 1 |
| Bintaher, A | 1 |
| Hashim, A | 1 |
| Abdelrahim, M | 1 |
| Afzal, M | 1 |
| El-Enany, R | 1 |
| El-Hamid, M | 1 |
| Bakdach, D | 1 |
| Karic, E | 1 |
| Shehatta, A | 1 |
| Ibrahim, AS | 1 |
| Lance, M | 1 |
| Hssain, AA | 1 |
| Hassan, I | 1 |
| Wang, J | 1 |
| Song, Q | 1 |
| Yang, S | 2 |
| Wang, H | 3 |
| Meng, S | 1 |
| Huang, L | 1 |
| Li, Q | 2 |
| Xu, J | 1 |
| Xie, J | 1 |
| Huang, Y | 1 |
| Novoa, J | 1 |
| Hardy, G | 1 |
| Manzanares, W | 1 |
| Lu, D | 1 |
| Mao, W | 2 |
| Pereira, AG | 1 |
| Costa, NA | 2 |
| Amancio, SCP | 1 |
| Okoshi, MP | 1 |
| Zornoff, LAM | 1 |
| Azevedo, PS | 2 |
| Minicucci, MF | 2 |
| de Paiva, SAR | 1 |
| Polegato, BF | 1 |
| Dhanani, LY | 1 |
| Totton, RR | 1 |
| Jara-Quijada, E | 1 |
| Pérez-Won, M | 1 |
| Tabilo-Munizaga, G | 1 |
| Lemus-Mondaca, R | 1 |
| González-Cavieres, L | 1 |
| Palma-Acevedo, A | 1 |
| Herrera-Lavados, C | 1 |
| Milovanovic, S | 1 |
| Grzegorczyk, A | 1 |
| Świątek, Ł | 1 |
| Grzęda, A | 1 |
| Dębczak, A | 1 |
| Tyskiewicz, K | 1 |
| Konkol, M | 1 |
| Li, Y | 3 |
| Chang, P | 2 |
| Sankaran, S | 1 |
| Jang, H | 1 |
| Nie, Y | 1 |
| Zeng, A | 1 |
| Hussain, S | 1 |
| Wu, JY | 1 |
| Chen, X | 2 |
| Shi, L | 2 |
| Senapati, A | 1 |
| Chetri, BK | 1 |
| Mitra, S | 1 |
| Shelke, RG | 1 |
| Rangan, L | 1 |
| Chauhan, AS | 1 |
| Tiwari, M | 1 |
| Indoliya, Y | 1 |
| Mishra, SK | 1 |
| Lavania, UC | 1 |
| Chauhan, PS | 1 |
| Chakrabarty, D | 1 |
| Tripathi, RD | 1 |
| Akaputra, R | 1 |
| Hatta, M | 1 |
| Massi, MN | 1 |
| Djaharuddin, I | 1 |
| Bukhari, A | 1 |
| Aminuddin, A | 1 |
| Santoso, A | 1 |
| Natzir, R | 1 |
| Bahar, B | 1 |
| Fachri, M | 1 |
| Farsida, F | 1 |
| Fathimah, A | 1 |
| Ubaidah, FM | 1 |
| Sridiana, E | 1 |
| Dwiyanti, R | 1 |
| Syukri, A | 1 |
| Junita, AR | 1 |
| Febrianti, A | 1 |
| Primaguna, MR | 1 |
| Azhar, A | 1 |
| Rajaure, YS | 1 |
| Thapa, B | 1 |
| Budhathoki, L | 1 |
| Rana, SR | 1 |
| Khadka, M | 1 |
| Batchu, UR | 1 |
| Surapaneni, JR | 1 |
| Cheemalamarri, C | 1 |
| Mandava, K | 1 |
| Puvvada, N | 1 |
| Shetty, PR | 1 |
| Mv, S | 1 |
| Ranjbarian, P | 1 |
| Goudarzi, F | 1 |
| Akya, A | 1 |
| Heidarinia, H | 1 |
| Farasat, A | 1 |
| Rostamian, M | 1 |
| Suri, K | 1 |
| Rajput, N | 1 |
| Sharma, P | 1 |
| Omble, AD | 1 |
| Kulkarni, K | 1 |
| Gahlay, GK | 1 |
| Fernandez Garcia, E | 1 |
| Paudel, U | 1 |
| Noji, MC | 1 |
| Bowman, CE | 1 |
| Rustgi, AK | 1 |
| Pitarresi, JR | 1 |
| Wellen, KE | 1 |
| Arany, Z | 1 |
| Weissenrieder, JS | 1 |
| Foskett, JK | 1 |
| Lee, MS | 1 |
| Han, HJ | 1 |
| Choi, TI | 1 |
| Lee, KH | 1 |
| Baasankhuu, A | 1 |
| Kim, HT | 1 |
| Kim, CH | 1 |
| Redd, PS | 1 |
| Payero, L | 1 |
| Gilbert, DM | 1 |
| Page, CA | 1 |
| King, R | 1 |
| McAssey, EV | 1 |
| Bodie, D | 1 |
| Diaz, S | 1 |
| Hancock, CN | 1 |
| Lee, HS | 1 |
| Jung, S | 1 |
| Lee, SW | 1 |
| Kim, YT | 1 |
| Lee, J | 1 |
| Ren, T | 1 |
| Yu, Z | 1 |
| Yu, H | 1 |
| Deng, K | 1 |
| Wang, Z | 1 |
| Li, X | 1 |
| Wang, L | 2 |
| Xu, Y | 1 |
| Lascano, J | 1 |
| Riley, L | 1 |
| Khodayari, N | 1 |
| Brantly, M | 1 |
| Gupta, R | 1 |
| Pradhan, J | 1 |
| Haldar, A | 1 |
| Murapaka, C | 1 |
| Chandra Mondal, P | 1 |
| Gao, R | 1 |
| Dai, TY | 1 |
| Meng, Z | 1 |
| Sun, XF | 1 |
| Liu, DX | 1 |
| Shi, MM | 1 |
| Li, HR | 1 |
| Kang, X | 1 |
| Bi, B | 1 |
| Zhang, YT | 1 |
| Xu, TW | 1 |
| Yan, JM | 1 |
| Jiang, Q | 1 |
| Helmchen, G | 1 |
| Guo, H | 1 |
| Xiang, W | 1 |
| Fang, Y | 1 |
| Lin, Y | 1 |
| An, X | 1 |
| Jiang, D | 1 |
| Cao, Q | 1 |
| Xu, F | 1 |
| Shiigi, H | 1 |
| Wang, W | 1 |
| Chen, Z | 1 |
| Akosman, I | 1 |
| Mortenson, R | 1 |
| Lans, A | 1 |
| De La Garza Ramos, R | 1 |
| Eleswarapu, A | 1 |
| Yassari, R | 1 |
| Fourman, MS | 1 |
| Jana, S | 1 |
| Evans, EGB | 1 |
| Jang, HS | 1 |
| Zhang, S | 2 |
| Zhang, H | 1 |
| Rajca, A | 1 |
| Gordon, SE | 1 |
| Zagotta, WN | 1 |
| Stoll, S | 1 |
| Mehl, RA | 1 |
| Miller, S | 1 |
| Lee, DA | 1 |
| Muhimpundu, S | 1 |
| Maxwell, CA | 1 |
| Liu, Z | 2 |
| Shen, F | 1 |
| Tong, Q | 1 |
| Tang, M | 1 |
| Peng, M | 1 |
| Jiao, Z | 1 |
| Jiang, Y | 1 |
| Ao, L | 1 |
| Fu, W | 1 |
| Lv, X | 1 |
| Jiang, G | 1 |
| Hou, L | 1 |
| Tu, WC | 1 |
| McManamen, AM | 1 |
| Su, X | 1 |
| Jeacopello, I | 1 |
| Takezawa, MG | 1 |
| Hieber, DL | 1 |
| Hassan, GW | 1 |
| Lee, UN | 1 |
| Anana, EV | 1 |
| Locknane, MP | 1 |
| Stephenson, MW | 1 |
| Shinkawa, VAM | 1 |
| Wald, ER | 1 |
| DeMuri, GP | 1 |
| Adams, KN | 1 |
| Berthier, E | 1 |
| Thongpang, S | 1 |
| Theberge, AB | 1 |
| Jiang, L | 1 |
| Li, Z | 1 |
| Dong, Q | 1 |
| Rong, X | 1 |
| Dong, G | 1 |
| Huang, J | 2 |
| Liang, Y | 1 |
| Sun, S | 1 |
| Zhang, R | 1 |
| Miao, Z | 1 |
| Senju, C | 1 |
| Nakazawa, Y | 1 |
| Oso, T | 1 |
| Shimada, M | 1 |
| Kato, K | 1 |
| Matsuse, M | 1 |
| Tsujimoto, M | 1 |
| Masaki, T | 1 |
| Miyazaki, Y | 1 |
| Fukushima, S | 1 |
| Tateishi, S | 1 |
| Utani, A | 1 |
| Murota, H | 1 |
| Tanaka, K | 1 |
| Mitsutake, N | 1 |
| Moriwaki, S | 1 |
| Nishigori, C | 1 |
| Ogi, T | 1 |
| Liu, C | 1 |
| Zhang, X | 1 |
| Wang, B | 1 |
| Luo, Z | 1 |
| Qian, D | 1 |
| Liu, J | 1 |
| Waterhouse, GIN | 1 |
| Barbosa, M | 1 |
| Marques-Sá, J | 1 |
| Carvalho, C | 1 |
| Fernandes, V | 1 |
| Grilli, D | 1 |
| Smetana, V | 1 |
| Ahmed, SJ | 1 |
| Shtender, V | 1 |
| Pani, M | 1 |
| Manfrinetti, P | 1 |
| Mudring, AV | 1 |
| Kuang, Y | 1 |
| Yang, D | 1 |
| Gai, S | 1 |
| He, F | 1 |
| An, B | 1 |
| Yang, P | 1 |
| Notini, L | 1 |
| Schulz, K | 1 |
| Kubeneck, LJ | 1 |
| Grigg, ARC | 1 |
| Rothwell, KA | 1 |
| Fantappiè, G | 1 |
| ThomasArrigo, LK | 1 |
| Kretzschmar, R | 1 |
| Siswanto, FM | 1 |
| Okukawa, K | 1 |
| Tamura, A | 1 |
| Oguro, A | 1 |
| Imaoka, S | 1 |
| Kim, CG | 1 |
| Jung, M | 1 |
| Kim, HS | 1 |
| Lee, CK | 1 |
| Jeung, HC | 1 |
| Koo, DH | 1 |
| Bae, WK | 1 |
| Zang, DY | 1 |
| Kim, BJ | 1 |
| Kim, H | 1 |
| Yun, UJ | 1 |
| Che, J | 1 |
| Park, S | 1 |
| Kim, TS | 1 |
| Kwon, WS | 1 |
| Park, J | 1 |
| Cho, SW | 1 |
| Nam, CM | 1 |
| Chung, HC | 1 |
| Rha, SY | 1 |
| Colombo, N | 1 |
| Van Gorp, T | 1 |
| Matulonis, UA | 1 |
| Oaknin, A | 1 |
| Grisham, RN | 1 |
| Fleming, GF | 1 |
| Olawaiye, AB | 1 |
| Nguyen, DD | 1 |
| Greenstein, AE | 1 |
| Custodio, JM | 1 |
| Pashova, HI | 1 |
| Tudor, IC | 1 |
| Lorusso, D | 1 |
| Zhou, F | 1 |
| Jiang, Z | 1 |
| Liang, H | 1 |
| Ru, S | 1 |
| Bettiol, AA | 1 |
| Gao, W | 1 |
| Lipsyc-Sharf, M | 1 |
| Jain, E | 1 |
| Collins, LC | 1 |
| Rosenberg, SM | 1 |
| Ruddy, KJ | 1 |
| Tamimi, RM | 1 |
| Schapira, L | 1 |
| Come, SE | 1 |
| Peppercorn, JM | 1 |
| Borges, VF | 1 |
| Warner, E | 1 |
| Snow, C | 1 |
| Krop, IE | 1 |
| Kim, D | 2 |
| Weiss, J | 1 |
| Zanudo, JGT | 1 |
| Partridge, AH | 1 |
| Wagle, N | 1 |
| Waks, AG | 1 |
| Liu, X | 1 |
| Cocchi, MN | 4 |
| Chase, M | 3 |
| Gong, MN | 1 |
| Gong, J | 2 |
| Parikh, SM | 1 |
| Ngo, L | 3 |
| Berlin, N | 1 |
| Zhou, Y | 1 |
| Chen, Q | 1 |
| Zhong, S | 1 |
| Liu, H | 1 |
| Koh, K | 1 |
| Chen, H | 1 |
| He, J | 1 |
| Chen, J | 1 |
| Liu, S | 1 |
| Lin, L | 1 |
| Zhang, Y | 1 |
| Xiao, S | 1 |
| Cao, S | 1 |
| Yan, B | 2 |
| Deng, J | 1 |
| Gu, J | 1 |
| Tao, Y | 1 |
| Huang, C | 1 |
| Lai, C | 1 |
| Yong, Q | 1 |
| Shen, Y | 1 |
| Gong, Z | 1 |
| Cao, J | 1 |
| Yao, Y | 1 |
| Zhao, J | 1 |
| Liu, K | 1 |
| Liu, B | 1 |
| Feng, S | 1 |
| Chandran, V | 1 |
| Kunjan, C | 1 |
| Veerapandian, V | 1 |
| Kannan, R | 1 |
| Zhang, T | 1 |
| von Gunten, U | 1 |
| Caruso, FR | 1 |
| Goulart, CDL | 1 |
| Jr, JCB | 1 |
| de Oliveira, CR | 1 |
| Mendes, RG | 1 |
| Arena, R | 1 |
| Borghi-Silva, A | 1 |
| Carrasco-Nuñes, N | 1 |
| Romano, M | 1 |
| Cabeza, M | 1 |
| Jiang, B | 1 |
| Chen, D | 1 |
| Zhao, C | 1 |
| Ma, Y | 1 |
| Yang, W | 1 |
| Shen, X | 1 |
| Satheeshkumar, K | 1 |
| Saravanakumar, P | 1 |
| Kalavathi, A | 1 |
| Vennila, KN | 1 |
| Elango, KP | 1 |
| Mues Genannt Koers, L | 1 |
| Prevost, D | 1 |
| Paulssen, E | 1 |
| Hoehr, C | 1 |
| Ulhassan, Z | 1 |
| He, D | 1 |
| Khan, AR | 1 |
| Salam, A | 1 |
| Azhar, W | 1 |
| Muhammad, S | 1 |
| Ali, S | 1 |
| Hamid, Y | 1 |
| Khan, I | 1 |
| Sheteiwy, MS | 1 |
| Zhou, W | 1 |
| Wang, X | 1 |
| Xie, Q | 1 |
| Wang, Y | 1 |
| Lü, H | 1 |
| Fu, M | 1 |
| Wang, D | 1 |
| Sevransky, J | 1 |
| Mitchell, AB | 1 |
| Ryan, TE | 1 |
| Gillion, AR | 1 |
| Wells, LD | 1 |
| Muthiah, MP | 1 |
| Scott, HF | 1 |
| Ho, VP | 1 |
| Kaafarani, H | 1 |
| Rattan, R | 1 |
| Namias, N | 1 |
| Evans, H | 1 |
| Zakrison, TL | 1 |
| Yankama, T | 1 |
| Andersen, LW | 5 |
| Huang, DT | 2 |
| Wald, EL | 1 |
| Sanchez-Pinto, LN | 1 |
| Smith, CM | 1 |
| Moran, T | 1 |
| Badke, CM | 1 |
| Barhight, MF | 1 |
| Malakooti, MR | 1 |
| Frei, DR | 1 |
| Eastwood, GM | 2 |
| French, CJ | 1 |
| Deane, AM | 2 |
| Shehabi, Y | 2 |
| Hajjar, LA | 1 |
| Oliveira, G | 1 |
| Orford, N | 2 |
| Edney, SJ | 1 |
| Hunt, AL | 1 |
| Judd, HL | 1 |
| Bitker, L | 1 |
| Cioccari, L | 1 |
| Naorungroj, T | 1 |
| Bates, S | 1 |
| McGain, F | 1 |
| Hudson, EP | 1 |
| Al-Bassam, W | 1 |
| Dwivedi, DB | 1 |
| Peppin, C | 1 |
| McCracken, P | 1 |
| Orosz, J | 1 |
| Bailey, M | 2 |
| Kalil, AC | 2 |
| Obi, J | 1 |
| Pastores, SM | 1 |
| Ramanathan, LV | 1 |
| Yang, J | 1 |
| Halpern, NA | 1 |
| Liao, Y | 1 |
| Guan, J | 1 |
| Guo, Y | 1 |
| Zhao, M | 1 |
| Hu, J | 1 |
| Zhou, J | 1 |
| Cen, Z | 1 |
| Tang, Y | 1 |
| Carr, AC | 2 |
| Long, MT | 1 |
| Kory, P | 1 |
| Marik, P | 1 |
| Coloretti, I | 1 |
| Biagioni, E | 1 |
| Venturelli, S | 1 |
| Munari, E | 1 |
| Tosi, M | 1 |
| Roat, E | 1 |
| Brugioni, L | 1 |
| Gelmini, R | 1 |
| Venturelli, C | 1 |
| Girardis, M | 2 |
| Shi, R | 1 |
| Tie, H | 1 |
| Miyamoto, Y | 1 |
| Aso, S | 1 |
| Iwagami, M | 1 |
| Yasunaga, H | 1 |
| Matsui, H | 1 |
| Fushimi, K | 1 |
| Hamasaki, Y | 1 |
| Nangaku, M | 1 |
| Doi, K | 1 |
| Vail, EA | 1 |
| Wunsch, H | 1 |
| Pinto, R | 1 |
| Bosch, NA | 1 |
| Walkey, AJ | 1 |
| Lindenauer, PK | 1 |
| Gershengorn, HB | 1 |
| Maley, JH | 1 |
| Law, AC | 1 |
| Stevens, JP | 1 |
| Jo, IJ | 2 |
| Hou, PC | 1 |
| Doshi, PB | 1 |
| Sherwin, RL | 1 |
| McCannon, JB | 1 |
| Hershey, M | 1 |
| Hilewitz, A | 1 |
| Korotun, M | 1 |
| Becker, LB | 1 |
| Otero, RM | 1 |
| Uduman, J | 1 |
| Sen, A | 1 |
| Fowler, R | 1 |
| Vincent, JL | 1 |
| Riessen, R | 1 |
| Qian, X | 1 |
| Zhang, Z | 1 |
| Li, F | 1 |
| Wu, L | 1 |
| Petsakul, S | 1 |
| Morakul, S | 1 |
| Tangsujaritvijit, V | 1 |
| Kunawut, P | 1 |
| Singhatas, P | 1 |
| Sanguanwit, P | 1 |
| Raj, KM | 1 |
| Baranwal, AK | 1 |
| Attri, SV | 1 |
| Jayashree, M | 1 |
| Kumar-M, P | 1 |
| Patial, A | 1 |
| Saini, AG | 1 |
| Zayed, Y | 1 |
| Alzghoul, BN | 1 |
| Banifadel, M | 1 |
| Venigandla, H | 1 |
| Hyde, R | 1 |
| Sutchu, S | 1 |
| Khasawneh, M | 1 |
| Borok, Z | 1 |
| Urbine, D | 1 |
| Jantz, M | 1 |
| Reddy, R | 1 |
| Ge, Z | 1 |
| Liu, Y | 1 |
| Xiang, J | 1 |
| Gao, Y | 1 |
| Walline, JH | 1 |
| Lu, X | 1 |
| Yu, S | 1 |
| Zhao, L | 1 |
| Lee, YR | 1 |
| Vo, K | 1 |
| Varughese, JT | 1 |
| Prasad, N | 1 |
| Meyer, NJ | 1 |
| Perman, SM | 1 |
| Mikkelsen, ME | 1 |
| Hollander, J | 1 |
| Gaieski, DF | 1 |
| Fong, KM | 1 |
| Au, SY | 1 |
| Ng, GWY | 1 |
| Oudemans-van Straaten, HM | 1 |
| Elbers, PWG | 1 |
| Spoelstra-de Man, AME | 1 |
| Møller, MH | 1 |
| Laake, JH | 1 |
| Myburgh, JA | 1 |
| Alhazzani, W | 1 |
| Perner, A | 1 |
| Marik, PE | 4 |
| Hooper, MH | 3 |
| Khangoora, V | 2 |
| Rivera, R | 2 |
| Catravas, J | 2 |
| Flannery, AH | 3 |
| Bastin, MLT | 1 |
| Magee, CA | 1 |
| Bensadoun, ES | 1 |
| Uber, A | 1 |
| Stankovic, N | 1 |
| Johnson, DW | 1 |
| Cawcutt, KA | 1 |
| Gritsenko, D | 1 |
| Papadopoulos, J | 1 |
| Altshuler, D | 1 |
| Lee, YI | 1 |
| Altshuler, J | 1 |
| Michelow, IC | 1 |
| Alhinai, Z | 1 |
| Dennehy, PH | 1 |
| Walter, JM | 1 |
| Singer, BD | 1 |
| Belsky, JB | 1 |
| Wira, CR | 1 |
| Jacob, V | 1 |
| Sather, JE | 1 |
| Lee, PJ | 1 |
| Hager, DN | 1 |
| Martin, GS | 1 |
| Sevransky, JE | 1 |
| Olanipekun, TO | 1 |
| Bakinde, N | 1 |
| Effoe, VS | 1 |
| Snyder, R | 1 |
| Woolum, JA | 2 |
| Patel, JJ | 1 |
| Bergl, P | 1 |
| Parikh, R | 1 |
| Belok, SH | 1 |
| Swamy, L | 1 |
| Reardon, CC | 1 |
| Frei, D | 1 |
| French, C | 1 |
| Guirguis, E | 1 |
| Grace, Y | 1 |
| Maarsingh, H | 1 |
| Tran, TC | 1 |
| Tkachuk, E | 1 |
| Weiss, SL | 1 |
| Blowey, B | 1 |
| Keele, L | 1 |
| Ganetzky, R | 1 |
| Murali, CN | 1 |
| Fitzgerald, JC | 1 |
| Sutton, RM | 1 |
| Berg, RA | 1 |
| Kong, T | 1 |
| Shin, J | 1 |
| Lee, HJ | 1 |
| You, KM | 1 |
| Sadaka, F | 1 |
| Grady, J | 1 |
| Organti, N | 1 |
| Donepudi, B | 1 |
| Korobey, M | 1 |
| Tannehill, D | 1 |
| O'Brien, J | 1 |
| Gut, AL | 1 |
| de Souza Dorna, M | 1 |
| Pimentel, JA | 1 |
| Cozzolino, SM | 1 |
| Fernandes, AA | 1 |
| Zornoff, LA | 1 |
| de Paiva, SA | 1 |
| Busani, S | 1 |
| Bonvecchio, C | 1 |
| Gaspari, A | 1 |
| Malagoli, M | 1 |
| Todeschini, A | 1 |
| Cautero, N | 1 |
| Tidswell, M | 1 |
| Giberson, T | 1 |
| Wolfe, R | 1 |
| Smithline, H | 1 |
| Karlsson, M | 1 |
| STERNIERI, E | 1 |
| BERNARDI, M | 1 |
| GIAROLI, M | 1 |
| TAKAHASHI, R | 1 |
| HOSAKA, M | 1 |
| TAKEFUJI, H | 1 |
| RIBOTTA, S | 1 |
| LICCI, W | 1 |
| BOISSIER, JR | 1 |
| VIARS, P | 1 |
| SIMON, P | 1 |
| Diltoer, MW | 1 |
| Troubleyn, J | 1 |
| Lauwers, R | 1 |
| De Wijngaard, S | 1 |
| Vercammen, MJ | 1 |
| Hubloue, I | 1 |
| Huyghens, LP | 1 |
| Bernsmeier, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combination Therapy of Vitamin C and Thiamine for Septic Shock: Multi-center, Double-blinded, Randomized, Controlled Study[NCT03756220] | Phase 2 | 116 participants (Actual) | Interventional | 2018-12-01 | Completed | ||
| Initiation of Vitamin C, Thiamine and Hydrocortisone Therapy for Septic Shock in Adults: A Randomized Clinical Trial[NCT03872011] | Phase 3 | 408 participants (Actual) | Interventional | 2019-02-19 | Completed | ||
| Ascorbic Ccid, Hydrocortisone, and Thiamine in Sepsis and Septic Shock - A Randomized, Double-Blind, Placebo-Controlled Trial[NCT03389555] | Phase 2/Phase 3 | 205 participants (Actual) | Interventional | 2018-02-09 | Completed | ||
| Impact of Thiamine Supplementation on Mortality in Septic Shock. A Controlled Before-and-after Study.[NCT05840718] | 80 participants (Anticipated) | Observational | 2023-09-30 | Not yet recruiting | |||
| Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock: a Randomized Clinical Study (VITAMIN TRIAL)[NCT05192213] | Phase 3 | 1,090 participants (Anticipated) | Interventional | 2021-08-01 | Recruiting | ||
| The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial (VITAMINS Trial) - A Prospective, Feasibility, Pilot, Multi-centre, Randomised, Open-label Controlled Trial[NCT03333278] | Phase 2 | 216 participants (Actual) | Interventional | 2018-05-02 | Completed | ||
| Clinical Efficacy of Megadose Vitamin C in Sepsis (CEMVIS): A Multicenter, Randomized, Single-blind, Placebo-controlled Clinical Trial[NCT05194189] | Phase 2 | 152 participants (Anticipated) | Interventional | 2022-02-08 | Recruiting | ||
| Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock: A Prospective Study[NCT03258684] | 80 participants (Actual) | Interventional | 2017-09-25 | Completed | |||
| High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients, A Retrospective Cohort Study[NCT04710329] | 78 participants (Actual) | Observational | 2021-01-16 | Completed | |||
| Corticosteroids to Reduce Inflammation in Severe Pancreatitis: A Randomized, Controlled Study[NCT05160506] | Phase 2 | 86 participants (Anticipated) | Interventional | 2022-03-06 | Recruiting | ||
| Effect of Intravenous Vitamin C on Sequential Organ Failure Assessment (SOFA) Score Among Septic Patients: Randomized Controlled Trial[NCT04137276] | 33 participants (Actual) | Interventional | 2019-04-01 | Completed | |||
| The Thiamine Administration After Cardiac Surgery Trial[NCT04641104] | Phase 4 | 200 participants (Actual) | Interventional | 2020-11-20 | Completed | ||
| Thiamine as a Renal Protective Agent in Septic Shock: A Randomized, Controlled Study[NCT03550794] | Phase 2 | 95 participants (Actual) | Interventional | 2018-09-04 | Completed | ||
| Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock[NCT03380507] | Phase 2/Phase 3 | 106 participants (Actual) | Interventional | 2018-03-17 | Terminated (stopped due to The research is no longer funded and terminated due to futility) | ||
| Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis.[NCT03422159] | Phase 2 | 140 participants (Actual) | Interventional | 2018-02-05 | Completed | ||
| A Randomized, Double Blind, Placebo-Controlled Study to Investigate the Effects of Vitamin C, Hydrocortisone and Thiamine on the Outcome of Patients With Severe Sepsis and Septic Shock[NCT03335124] | Phase 4 | 5 participants (Actual) | Interventional | 2017-09-26 | Terminated (stopped due to Due to insufficient recruitment) | ||
| Effect of Combined Vitamin C, Stress-dose Steroids, and Thiamine on Cerebral Autoregulation and Functional Outcomes of Patients With Septic Shock[NCT03649633] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2018-09-06 | Recruiting | ||
| Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock[NCT03828929] | Phase 3 | 3 participants (Actual) | Interventional | 2019-10-15 | Terminated (stopped due to Recent similar studies have been completed and published showing no benefit to the intervention.) | ||
| Early High-dose Vitamin C in Post-cardiac Arrest Syndrome[NCT03509662] | Phase 2 | 270 participants (Anticipated) | Interventional | 2019-10-07 | Recruiting | ||
| A Randomized, Double Blind, Placebo-Controlled Trial to Investigate the Effect of Vitamin C, Hydrocortisone and Thiamine on the Outcome of Patients With Septic Shock[NCT03592693] | Phase 2 | 400 participants (Anticipated) | Interventional | 2018-09-06 | Recruiting | ||
| Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia: a Randomized, Placebo-controlled Trial[NCT03451266] | Phase 1 | 34 participants (Actual) | Interventional | 2018-04-07 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Mortality rate (NCT03389555)
Timeframe: Enrollment until 30-days after enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 35 |
| Placebo | 29 |
Home hospital disposition in patients who survive to discharge (NCT03389555)
Timeframe: Enrollment until hospital discharge, death, or 30-days, whichever comes first.
| Intervention | Participants (Count of Participants) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 34 |
| Placebo | 35 |
Hospital mortality rate (NCT03389555)
Timeframe: Enrollment until hospital discharge, death, or 30-days. Whichever comes first.
| Intervention | Participants (Count of Participants) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 28 |
| Placebo | 23 |
Number of days that the patient was not in the ICU. Timeframe listed below. (NCT03389555)
Timeframe: From enrollment until 28 days after enrollment
| Intervention | Days (Median) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 22 |
| Placebo | 21 |
ICU mortality rate (NCT03389555)
Timeframe: Enrollment until ICU discharge, death, or 30-days. Whichever comes first.
| Intervention | Participants (Count of Participants) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 23 |
| Placebo | 20 |
"Describes if patient has delirium as defined by the Confusion Assessment Method (CAM)-ICU. The CAM-ICU method requires that the patient have 3 features to qualify for delirium:~Acute Onset of Changes or Fluctuations in the Course of Mental Status (AND )~Inattention (AND)~Disorganized thinking (OR) Altered Level of Consciousness" (NCT03389555)
Timeframe: On day 3 (at approximately 72 hours) after the first study drug dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 31 |
| Placebo | 35 |
"Development of renal failure as defined by a Kidney Disease Improving Global Outcomes [KDIGO] stage 3 or higher. There are 3 stages in the KDIGO scale with stage 3 being the worst (corresponds to renal failure).~Stage 1- serum creatinine 1.5 to 1.9 times baseline OR an increase in serum creatinine ≥ 0.3 mg/dL OR urine output < 0.5ml/kg/hour for 6-12 hours. Stage 2- serum creatinine 2.0-2.9 times baseline OR urine output <0.5mg/kg/hour for ≥ 12 hours Stage 3- serum creatinine 3.0 times baseline (or serum creatinine of more than or equal to 4.0 mg/dl with an acute increase of at least 0.5 mg/dl) (OR) Urine output less than 0.3 ml/kg/hour for 24 hours or anuria for 12 hours or new renal replacement therapy" (NCT03389555)
Timeframe: Enrollment until 7-days or discharge from the ICU
| Intervention | Participants (Count of Participants) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 32 |
| Placebo | 27 |
Days not receiving vasopressor (NCT03389555)
Timeframe: Vasopressor free days over the first 7-days after enrollment
| Intervention | Days (Median) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 5 |
| Placebo | 4 |
Days not receiving invasive mechanical ventilation (NCT03389555)
Timeframe: Ventilator free days over the first 7-days after enrollment
| Intervention | Days (Median) |
|---|---|
| Vitamin C, Vitamin B1, Corticosteroids | 6 |
| Placebo | 6 |
Sequential Organ Failure Assessment (SOFA) Score at Baseline and 72 Hours. The SOFA score ranges from a minimum of 0 to a maximum of 24, with higher scores meaning worse outcomes. (NCT03389555)
Timeframe: Enrollment to 72-hours
| Intervention | Units on a scale (Mean) | |
|---|---|---|
| Enrollment SOFA score | 72 hour SOFA score | |
| Placebo | 9.2 | 5.1 |
| Vitamin C, Vitamin B1, Corticosteroids | 9.1 | 4.4 |
Change in lactate level between enrollment and 72 hours after enrollment (NCT03550794)
Timeframe: From time of enrollment until 72 hours after enrollment
| Intervention | mmol/L (Median) |
|---|---|
| Thiamine | 1.65 |
| Placebo | 1.95 |
Change in Sequential Organ Failure Assessment Score (SOFA) score between enrollment and 72 hours after enrollment. SOFA scores are reported on a scale between 0-24, with 0 representing best outcome and 24 representing worst outcome. (NCT03550794)
Timeframe: Time of enrollment until 72 hours after enrollment
| Intervention | units on a scale (Mean) |
|---|---|
| Thiamine | 8.09 |
| Placebo | 9.61 |
Days alive and free of the ICU through day 28 (NCT03550794)
Timeframe: From date of enrollment until 28 days after enrollment
| Intervention | days (Median) |
|---|---|
| Thiamine | 22.5 |
| Placebo | 0.0 |
Length of hospital stay truncated at 60 days (NCT03550794)
Timeframe: From date of enrollment until discharge from the hospital or date of death, whichever comes first, up to 60 days after enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Thiamine | 15 |
| Placebo | 25 |
Change in creatinine over time (NCT03550794)
Timeframe: Enrollment to 72-hours
| Intervention | mg/dL (Mean) |
|---|---|
| Thiamine | 2.24 |
| Placebo | 2.79 |
Acute renal failure as defined by the KDIGO (Kidney Disease Improving Global Outcomes) AKI (Acute Kidney Injury) criteria. In brief, a patient can meet these criteria if their serum creatinine increases (for example, serum creatinine increases to 1.5x or higher of baseline serum creatinine, or if it crosses 4mg/dL), or if renal replacement therapy is initiated, or if urine output decreases (for example, <0.5ml/kg/hour for 6-12 hours) or if patient becomes anuric (no urine production). (NCT03550794)
Timeframe: From date of enrollment until day of discharge from the index ICU admission or date of death, whichever comes first up until 60 days post-enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Thiamine | 23 |
| Placebo | 34 |
Number of participants who received renal replacement therapy in thiamine and placebo groups. (NCT03550794)
Timeframe: From date of enrollment until discharge from the intensive care unit (ICU) or date of death, whichever comes first, up to 60 days after enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Thiamine | 6 |
| Placebo | 10 |
Number of Participants with Delirium on Day 3 after enrollment (NCT03550794)
Timeframe: Day 3 after enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Thiamine | 25 |
| Placebo | 30 |
KIM-1, NGAL, Cystatin-C at 24-hours after enrollment (NCT03550794)
Timeframe: 24 hours after enrollment
| Intervention | pg/mL (Median) | ||
|---|---|---|---|
| KIM-1 | NGAL | Cystatin | |
| Placebo | 793.9 | 1558285.0 | 2183175.4 |
| Thiamine | 763.1 | 1067898.2 | 1689158.2 |
Defined as the day 4 post-randomization SOFA score minus the initial SOFA score. The Sequential Organ Failure Assessment (SOFA) Score is a mortality prediction score that is based on the degree of dysfunction of six organ systems. The score is calculated on admission and every 24 hours until discharge using the worst parameters measured during the prior 24 hours SOFA score ranges from 0 (no organ dysfunction) to 24 (highest possible score / organ dysfunction). (NCT03422159)
Timeframe: 4 days post-randomization
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Arm | 2.9 |
| Placebo Arm | 1.93 |
Time from admitting to discharge of hospital stay. (NCT03422159)
Timeframe: From admission to the hospital until final discharge, up to 28 days.
| Intervention | Days (Mean) |
|---|---|
| Treatment Arm | 11.5 |
| Placebo Arm | 11 |
In-hospital mortality rate. (NCT03422159)
Timeframe: Survival until hospital discharge, up to 28 days.
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Arm | 11 |
| Placebo Arm | 13 |
Time from admitting to ICU to discharge. (NCT03422159)
Timeframe: From admission to the ICU until final discharge from the ICU, up to an average of 7 days.
| Intervention | days (Mean) |
|---|---|
| Treatment Arm | 4.76 |
| Placebo Arm | 4.66 |
ICU mortality rate (NCT03422159)
Timeframe: From admission to hospital until final discharge from the ICU, up to 28 days.
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Arm | 6 |
| Placebo Arm | 10 |
PCT at 96 hours minus initial PCT, divided by the initial PCT multiplied by 100. (NCT03422159)
Timeframe: 4 days post-randomization
| Intervention | Percent (Mean) |
|---|---|
| Treatment Arm | 63 |
| Placebo Arm | 58 |
Defined as the time from starting the active treatment/placebo to discontinuation of all pressors. (NCT03422159)
Timeframe: From start of vasopressor medication to final discontinuation of vasopressor medication, up to 7 days.
| Intervention | hours (Mean) |
|---|---|
| HAT Treatment | 27 |
| Comparator | 53 |
Number of days alive and off of the ventilator at day 28. (NCT03422159)
Timeframe: 28 Days post-randomization
| Intervention | Days (Mean) |
|---|---|
| Treatment Arm | 22 |
| Placebo Arm | 22.4 |
18 reviews available for thiamine and Endotoxin Shock
| Article | Year |
|---|---|
Effect of Combined Hydrocortisone, Ascorbic Acid and Thiamine for Patients with Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Sepsis; Shock, Septic; Thiamine | 2021 |
Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.
Topics: Adult; Ascorbic Acid; Glucocorticoids; Humans; Network Meta-Analysis; Sepsis; Shock, Septic; Thiamin | 2022 |
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients.
Topics: Angiotensin II; Ascorbic Acid; Crystalloid Solutions; Disease Management; Drug Therapy, Combination; | 2022 |
The Use of Hydrocortisone, Ascorbic Acid and Thiamine in Patients with Sepsis and Septic Shock - A Systematic Review.
Topics: Ascorbic Acid; Drug Therapy, Combination; Humans; Hydrocortisone; Sepsis; Shock, Septic; Thiamine | 2023 |
Unanswered questions on the use of hydrocortisone, ascorbic acid, and thiamine therapy in sepsis and septic shock.
Topics: Ascorbic Acid; Drug Therapy, Combination; Humans; Hydrocortisone; Retrospective Studies; Sepsis; Sho | 2022 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobut | 2022 |
Impact of supplemental thiamin on lactate levels in adults with septic shock.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Lactic Acid; Observational Studies as Topic; Retrospective St | 2023 |
Thiamine pharmaconutrition in sepsis: Monotherapy, combined therapy, or neither? Current evidence on safety and efficacy.
Topics: Adult; Ascorbic Acid; Critical Illness; Humans; Micronutrients; Sepsis; Shock, Septic; Thiamine; Tra | 2023 |
Hydrocortisone Combined with Vitamin C and Thiamine in the Treatment of Sepsis/Septic Shock: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Intensive Care Units; Sepsis; Shock, Septic; Thiamine | 2023 |
Sepsis 2019: What Surgeons Need to Know.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidan | 2020 |
Treating sepsis with vitamin C, thiamine, and hydrocortisone: Exploring the quest for the magic elixir.
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Ascorbic Acid Deficiency; Clinical Protocols; Critical Illne | 2020 |
Intravenous thiamine for septic shock: A meta-analysis of randomized controlled trials.
Topics: Administration, Intravenous; Humans; Intensive Care Units; Mortality; Odds Ratio; Organ Dysfunction | 2020 |
Vitamin C, Thiamine, and Hydrocortisone in the Treatment of Sepsis: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Female; Humans; Hydrocortisone; Male; Middle Aged; Randomize | 2022 |
Thiamine combined with vitamin C in sepsis or septic shock: a systematic review and meta-analysis.
Topics: Ascorbic Acid; Humans; Sepsis; Shock, Septic; Thiamine; Vitamins | 2021 |
Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Sepsis; Shock, Septic; Thiamine | 2022 |
Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis.
Topics: Ascorbic Acid; Drug Therapy, Combination; Female; Fludrocortisone; Glucocorticoids; Humans; Male; Ra | 2021 |
A review of micronutrients in sepsis: the role of thiamine, l-carnitine, vitamin C, selenium and vitamin D.
Topics: Ascorbic Acid; Carnitine; Deficiency Diseases; Dietary Supplements; Humans; Micronutrients; Nutritio | 2018 |
Vitamin C, Thiamine, and Steroids in the Sepsis Conquest: Replete to Defeat.
Topics: Ascorbic Acid; Humans; Sepsis; Shock, Septic; Thiamine; Vitamins | 2020 |
16 trials available for thiamine and Endotoxin Shock
| Article | Year |
|---|---|
Biomarker Analysis for Combination Therapy of Vitamin C and Thiamine in Septic Shock: A Post-Hoc Study of the ATESS Trial.
Topics: Aged; Angiopoietin-2; Ascorbic Acid; Biomarkers; Double-Blind Method; Drug Therapy, Combination; Fem | 2022 |
Effect of Supplementation of Vitamin C and Thiamine on the Outcome in Sepsis: South East Asian Region.
Topics: Ascorbic Acid; Dietary Supplements; Humans; Malondialdehyde; Sepsis; Shock, Septic; Thiamine; Vitami | 2022 |
Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial.
Topics: Adult; Ascorbic Acid; Drug Therapy, Combination; Humans; Hydrocortisone; Saline Solution; Shock, Sep | 2022 |
EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL).
Topics: Adult; Ascorbic Acid; Humans; Hydrocortisone; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vitam | 2023 |
Effects of hydrocortisone combined with vitamin C and vitamin B1 versus hydrocortisone alone on microcirculation in septic shock patients: A pilot study.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Microcirculation; Pilot Projects; Shock, Septic; Thiamine | 2023 |
Effect of Thiamine on Clinical Outcomes in Septic Shock Patients: A Randomized, Double-Blinded Pilot Study.
Topics: Ascorbic Acid; Double-Blind Method; Humans; Pilot Projects; Shock, Septic; Thiamine | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Com | 2023 |
Ascorbic Acid, Corticosteroids and Thiamine in Sepsis (ACTS) protocol and statistical analysis plan: a prospective, multicentre, double-blind, randomised, placebo-controlled clinical trial.
Topics: Ascorbic Acid; Double-Blind Method; Drug Combinations; Glucocorticoids; Humans; Hydrocortisone; Mult | 2019 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Drug Therapy, Combinatio | 2020 |
Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study.
Topics: Adult; Ascorbic Acid; Humans; Organ Dysfunction Scores; Shock, Septic; Thiamine; Vitamins | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ascorbic Acid; Cross Infection; Drug Therapy, Combination; Fem | 2020 |
Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Middle Aged; Organ Dysfun | 2020 |
Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan.
Topics: Adult; Ascorbic Acid; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Hydrocortisone; | 2019 |
Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Ascorbic Acid; Double-Blind Method; Drug Combinations; Female; Human | 2019 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lactic Acid; Male; Middle Aged; Pilot | 2016 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Mid | 2017 |
52 other studies available for thiamine and Endotoxin Shock
| Article | Year |
|---|---|
Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness : A Nationwide Retrospective Observational Study.
Topics: Adult; Alcoholism; Critical Illness; Dietary Supplements; Humans; Male; Middle Aged; Retrospective S | 2022 |
Vitamin C for ≥ 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study.
Topics: Adolescent; Adult; Aged; Ascorbic Acid; Cohort Studies; Drug Therapy, Combination; Hospital Mortalit | 2022 |
Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study.
Topics: Ascorbic Acid; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Shock, | 2023 |
Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study.
Topics: Ascorbic Acid; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Shock, | 2023 |
Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study.
Topics: Ascorbic Acid; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Shock, | 2023 |
Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study.
Topics: Ascorbic Acid; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Shock, | 2023 |
Fetal demise and Wernicke-Korsakoff syndrome in a patient with hyperemesis gravidarum: a case report.
Topics: Adult; Female; Fetal Death; Humans; Hyperemesis Gravidarum; Korsakoff Syndrome; Pregnancy; Shock, Se | 2023 |
Thiamine for Septic Shock: Take Your Vitamins?
Topics: Ascorbic Acid; Humans; Pilot Projects; Shock, Septic; Thiamine; Vitamin A; Vitamin K; Vitamins | 2023 |
Vitamin C and Thiamine for Sepsis and Septic Shock.
Topics: Aged; Ascorbic Acid; Clinical Protocols; Critical Care; Female; Humans; Hydrocortisone; Infusions, I | 2020 |
Thiamine in Pediatric Sepsis: A Motivating Study.
Topics: Child; Humans; Hyperlactatemia; Retrospective Studies; Sepsis; Shock, Septic; Thiamine; Thiamine Def | 2019 |
Hydrocortisone-Ascorbic Acid-Thiamine Use Associated with Lower Mortality in Pediatric Septic Shock.
Topics: Adolescent; Ascorbic Acid; Child; Child, Preschool; Drug Combinations; Female; Humans; Hydrocortison | 2020 |
Lack of Benefit of High-Dose Vitamin C, Thiamine, and Hydrocortisone Combination for Patients With Sepsis.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Sepsis; Shock, Septic; Thiamine; Vitamins | 2020 |
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock: A Randomized Controlled Trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Critical Care; Drug Therapy, Combination; Fema | 2020 |
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock: A Randomized Controlled Trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Critical Care; Drug Therapy, Combination; Fema | 2020 |
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock: A Randomized Controlled Trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Critical Care; Drug Therapy, Combination; Fema | 2020 |
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock: A Randomized Controlled Trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Critical Care; Drug Therapy, Combination; Fema | 2020 |
Is the VITAMINS RCT indicating potential redundancy between corticosteroids and vitamin C?
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Ret | 2020 |
Vitamin C, Hydrocortisone, and Thiamine for Septic Shock.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Shock, Septic; Thiamine; Vitamins | 2020 |
Vitamin C, Hydrocortisone, and Thiamine for Septic Shock-In Reply.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Shock, Septic; Thiamine; Vitamins | 2020 |
Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study.
Topics: Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Ascorbic Acid; Case-Control Stud | 2020 |
Additional Trials of Vitamin C in Septic Shock: A Bag of Mixed Fruit.
Topics: Ascorbic Acid; Citrus sinensis; Fruit; Glucocorticoids; Humans; Sepsis; Shock, Septic; Thiamine | 2020 |
Benefit of hydrocortisone, thiamine, and vitamin C for patients with sepsis or septic shock? Too early to draw conclusions.
Topics: Anti-Inflammatory Agents; Ascorbic Acid; Humans; Hydrocortisone; Shock, Septic; Thiamine | 2020 |
Association Between IV Thiamine and Mortality in Patients With Septic Shock: A Nationwide Observational Study.
Topics: Administration, Intravenous; Adult; Female; Humans; Japan; Male; Norepinephrine; Retrospective Studi | 2020 |
Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Ascorbic Acid; Cohort Studies; Drug Therapy, Comb | 2020 |
Evidence and Our Daily Risk Trade-offs in the Care of Critically Ill Patients.
Topics: Adult; Ascorbic Acid; Critical Illness; Humans; Hydrocortisone; Patients; Shock, Septic; Thiamine | 2020 |
Vitamin C and thiamine for sepsis: time to go back to fundamental principles.
Topics: Ascorbic Acid; Humans; Sepsis; Shock, Septic; Thiamine; Vitamins | 2020 |
[Ascorbic acid, corticosteroids, and thiamine-effect on organ injury in septic shock].
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Humans; Hydrocortisone; Sepsis; Shock, Septic; Thiamine | 2021 |
Thiamine Status in Children with Septic Shock from a Developing Country: A Prospective Case-Control Study.
Topics: Aftercare; Case-Control Studies; Child; Developing Countries; Humans; Patient Discharge; Prospective | 2021 |
The relationship between vitamin C or thiamine levels and outcomes for severe sepsis patients admitted to the ICU.
Topics: Ascorbic Acid; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Male; Midd | 2021 |
How to Give Vitamin C a Cautious but Fair Chance in Severe Sepsis.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
The Magic Bullet in Sepsis or the Inflation of Chance Findings?
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
Response.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
Vitamin C in Sepsis: When It Seems Too Sweet, It Might (Literally) Be.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
Thiamine in septic shock patients with alcohol use disorders: An observational pilot study.
Topics: Aged; Alcoholism; Female; Humans; Male; Middle Aged; Pilot Projects; Practice Patterns, Physicians'; | 2018 |
Vitamin C Is Not Ready for Prime Time in Sepsis but a Solution Is Close.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
The Unsung Hero: Role of Thiamine in the 'Vitamin C Cocktail'.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
Hydrocortisone, Vitamin C and Thiamine for Sepsis: Whither the Ethics in Research?
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
Vitamin C and Sepsis: Framing the Postpublication Discussion.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2017 |
Glucometry When Using Vitamin C in Sepsis: A Note of Caution.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2018 |
Response.
Topics: Ascorbic Acid; Controlled Before-After Studies; Humans; Hydrocortisone; Retrospective Studies; Sepsi | 2018 |
Thiamine: An Essential Component of the Metabolic Resuscitation Protocol.
Topics: Humans; Lactic Acid; Resuscitation; Shock, Septic; Thiamine; Vitamin B Complex | 2018 |
Further Considerations on the Benefits of Thiamine Administration in Patients With Septic Shock.
Topics: Humans; Lactic Acid; Shock, Septic; Thiamine; Vitamin B Complex | 2019 |
The authors reply.
Topics: Humans; Lactic Acid; Shock, Septic; Thiamine | 2019 |
Thiamine and Difficulties in Differentiating Type A From B Lactic Acidosis.
Topics: Acidosis, Lactic; Humans; Lactic Acid; Shock, Septic; Thiamine; Thiamine Deficiency | 2019 |
The authors reply.
Topics: Humans; Lactic Acid; Shock, Septic; Thiamine | 2019 |
Adjunctive Therapies in the Management of Septic Shock.
Topics: Alcohol-Related Disorders; Humans; Pilot Projects; Sepsis; Shock, Septic; Thiamine | 2019 |
Matched Retrospective Cohort Study of Thiamine to Treat Persistent Hyperlactatemia in Pediatric Septic Shock.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Female; Hospitals, Pediatric; Humans; Hyperlactatem | 2019 |
Ascorbic Acid, Thiamine, and Steroids in Septic Shock: Propensity Matched Analysis.
Topics: Ascorbic Acid; Humans; Hydrocortisone; Intensive Care Units; Retrospective Studies; Sepsis; Shock, S | 2020 |
Vitamin C administration in the critically ill: a summary of recent meta-analyses.
Topics: Ascorbic Acid; Controlled Before-After Studies; Critical Illness; Humans; Hydrocortisone; Retrospect | 2019 |
Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock.
Topics: Biomarkers; Female; Glutathione Peroxidase; Hospital Mortality; Humans; Intensive Care Units; Length | 2014 |
Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock.
Topics: Biomarkers; Female; Glutathione Peroxidase; Hospital Mortality; Humans; Intensive Care Units; Length | 2014 |
Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock.
Topics: Biomarkers; Female; Glutathione Peroxidase; Hospital Mortality; Humans; Intensive Care Units; Length | 2014 |
Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock.
Topics: Biomarkers; Female; Glutathione Peroxidase; Hospital Mortality; Humans; Intensive Care Units; Length | 2014 |
Wernicke's encephalopathy in a malnourished surgical patient: a difficult diagnosis.
Topics: Brain Edema; Cerebral Hemorrhage; Dietary Supplements; Digestive System Surgical Procedures; Fatal O | 2014 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Antioxidant | 2017 |
[Research on the neurotropic action of hydroxocobalamin and its combination with pyridoxine HCl or with thiamine propvldisulfide. Preliminary note].
Topics: Humans; Hydroxocobalamin; Nervous System; Pyridoxine; Research; Shock; Shock, Septic; Thiamine | 1963 |
[CASES OF SHOCK-LIKE CONDITIONS. (2)].
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chloramphenicol; Cocaine; Cyanosis; | 1963 |
[THIAMINE SHOCK: CLINICAL CONTRIBUTION AND TREATMENT].
Topics: Anaphylaxis; Drug Hypersensitivity; Hydrocortisone; Methamphetamine; Oxygen Inhalation Therapy; Resp | 1964 |
[ON THE TOXICITY OF INTRAVENOUS THIAMINE IN THE RABBIT].
Topics: Injections; Injections, Intravenous; Pharmacology; Research; Shock; Shock, Septic; Thiamine; Toxicol | 1964 |
Ketosis and cardiac failure: common signs of a single condition.
Topics: Alcoholism; Beriberi; Cachexia; Diagnosis, Differential; Emergency Medical Services; Female; Heart F | 2004 |
[2. Consciousness disorders in surgery. (Internistic report)].
Topics: Blood Pressure; Brain; Cell Membrane Permeability; Cerebrovascular Disorders; Glucose; Hexokinase; H | 1967 |